Yuji Kawaguchi
6PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 23, 2024
Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring.Yuji Kawaguchi, Yuriko Hajika, Maho Rinka
|Oct 19, 2022
Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.Yuji Kawaguchi, Yuriko Hajika, Narumi Ashida
|Apr 11, 2022
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika
|Sep 22, 2021
Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes.Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika
|Mar 15, 2019
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal-bolus therapy).Yuji Kawaguchi, Jun Sawa, Chie Hamai
|Jun 28, 2018
Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles.Yuji Kawaguchi, Jun Sawa, Noriko Sakuma
Pageof 1
